000 | 01779 a2200517 4500 | ||
---|---|---|---|
005 | 20250515061725.0 | ||
264 | 0 | _c20070501 | |
008 | 200705s 0 0 eng d | ||
022 | _a1607-8454 | ||
024 | 7 |
_a10.1080/10245330600938182 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNabavizadeh, Seyed Hessamedin | |
245 | 0 | 0 |
_aThe prevalence of G6PD deficiency in blood transfusion recipients. _h[electronic resource] |
260 |
_bHematology (Amsterdam, Netherlands) _cFeb 2007 |
||
300 |
_a85-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAnemia _xetiology |
650 | 0 | 4 |
_aAnemia, Hemolytic _xetiology |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 |
_aBlood Donors _xstatistics & numerical data |
650 | 0 | 4 |
_aBlood Transfusion _xstandards |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aChloramphenicol _xadverse effects |
650 | 0 | 4 | _aContraindications |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aDiagnostic Tests, Routine |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucosephosphate Dehydrogenase Deficiency _xblood |
650 | 0 | 4 |
_aHematologic Tests _xadverse effects |
650 | 0 | 4 |
_aHematuria _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperbilirubinemia _xetiology |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aIran _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOxidants _xadverse effects |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTransfusion Reaction |
700 | 1 | _aAnushiravani, Amir | |
773 | 0 |
_tHematology (Amsterdam, Netherlands) _gvol. 12 _gno. 1 _gp. 85-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/10245330600938182 _zAvailable from publisher's website |
999 |
_c16920372 _d16920372 |